Cargando…

Case Report: Safe and Effective Sublingual Birch Allergen Immunotherapy in Two HIV-Positive Patients

Allergen-specific immunotherapy (AIT) is a safe, effective treatment for respiratory allergies (such as moderate-to-severe allergic rhinoconjunctivitis) that are not controlled by symptomatic medications. The indications and contraindications for AIT have been defined in international guidelines and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Latysheva, Elena, Nazarova, Evgeniya, Latysheva, Tatiana, Ilina, Natalia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8354585/ https://www.ncbi.nlm.nih.gov/pubmed/34385997 http://dx.doi.org/10.3389/fimmu.2021.599955

Ejemplares similares

Commentary: Sublingual Allergen Immunotherapy in HIV-Positive Patients
por: Chirumbolo, Salvatore
Publicado: (2016)

A prospective study comparing the efficacy and safety of two sublingual birch allergen preparations
por: Klimek, Ludger, et al.
Publicado: (2014)

Adjuvanting Allergen Extracts for Sublingual Immunotherapy: Calcitriol Downregulates CXCL8 Production in Primary Sublingual Epithelial Cells
por: Pelst, Michael P., et al.
Publicado: (2020)

A birch sublingual allergy immunotherapy tablet reduces rhinoconjunctivitis symptoms when exposed to birch and oak and induces IgG(4) to allergens from all trees in the birch homologous group
por: Couroux, Peter, et al.
Publicado: (2018)

Relevant Patient Benefit of Sublingual Immunotherapy with Birch Pollen Allergen Extract in Allergic Rhinitis: An Open, Prospective, Non-Interventional Study
por: Blome, Christine, et al.
Publicado: (2020)

Long-term effects of allergen sublingual immunotherapy
por: Bozek, Andrzej, et al.
Publicado: (2019)

Variation in allergen content in sublingual allergen immunotherapy with house dust mites
por: Moreno Benítez, F., et al.
Publicado: (2015)

Preparation of chemically stable allergen‐specific sublingual immunotherapy from Egyptian allergens
por: Abu El‐Enin, Mohammed A., et al.
Publicado: (2022)

Efficacy of dual sublingual immunotherapy with Japanese cedar pollen and house dust mite allergens in patients with allergic rhinitis sensitized to multiple allergens
por: Fujii, Tatsuya, et al.
Publicado: (2022)

Assessment of Immunogenicity of Adjuvanted Quadrivalent Inactivated Influenza Vaccine in Healthy People and Patients With Common Variable Immune Deficiency
por: Kostinova, Aristitsa Mikhailovna, et al.
Publicado: (2020)

Enhanced efficacy of sublingual immunotherapy by liposome-mediated delivery of allergen
por: Aliu, Have, et al.
Publicado: (2017)

Sublingual allergen immunotherapy for respiratory allergy: a systematic review
por: Blanco, Carlos, et al.
Publicado: (2018)

Adverse reactions and tolerability of high-dose sublingual allergen immunotherapy
por: Moral, Angel, et al.
Publicado: (2016)

Preventive Administration of Non-Allergenic Bet v 1 Peptides Reduces Allergic Sensitization to Major Birch Pollen Allergen, Bet v 1
por: Akinfenwa, Oluwatoyin, et al.
Publicado: (2021)

Assessment of stability and compatibility of dermatophagoides and blomia allergen mixture for sublingual immunotherapy
por: Morejón, Maytee Mateo, et al.
Publicado: (2015)

Recurrent rhombencephalomyelitis associated with allergen immunotherapy by mite antigen sublingual tablets
por: Kawajiri, Masakazu, et al.
Publicado: (2019)

Nondaily dosing schedule of allergen-specific sublingual immunotherapy: efficacy and safety
por: Abdelwahab, Heba Wagih, et al.
Publicado: (2023)

Sublingual Immunotherapy: How Sublingual Allergen Administration Heals Allergic Diseases; Current Perspective about the Mode of Action
por: Gotoh, Minoru, et al.
Publicado: (2021)

Fold stability during endolysosomal acidification is a key factor for allergenicity and immunogenicity of the major birch pollen allergen
por: Machado, Yoan, et al.
Publicado: (2016)

Intralymphatic Immunotherapy (ILIT) with both grass and birch allergen- a randomized controlled trial
por: Hellkvist, Laila, et al.
Publicado: (2015)

Real‐world benefits of allergen immunotherapy for birch pollen‐associated allergic rhinitis and asthma
por: Wahn, Ulrich, et al.
Publicado: (2018)

Acupuncture as an add-on therapy to sublingual allergen-specific immunotherapy for patients with allergic rhinitis
por: Li, Jiang-hua, et al.
Publicado: (2019)

The Molecular Allergen Recognition Profile in China as Basis for Allergen-Specific Immunotherapy
por: D’souza, Nishelle, et al.
Publicado: (2021)

Characteristics and management of sublingual allergen immunotherapy in children with allergic rhinitis and asthma induced by house dust mite allergens
por: Trebuchon, Florence, et al.
Publicado: (2014)

Predicting Success of Allergen-Specific Immunotherapy
por: Zissler, Ulrich M., et al.
Publicado: (2020)

Efficacy and safety of sublingual immunotherapy for allergic rhinitis: A network meta-analysis
por: Ji, Zao, et al.
Publicado: (2023)

OR05-4 Case Series of Transmasculine Adolescents Who Developed Polycythemia on Gender Affirming Hormone Therapy
por: Latysheva, Natalya
Publicado: (2022)

Intralymphatic immunotherapy with one or two allergens renders similar clinical response in patients with allergic rhinitis due to birch and grass pollen
por: Ahlbeck, Lars, et al.
Publicado: (2022)

Lung-derived innate cytokines: new epigenetic targets of allergen-specific sublingual immunotherapy
por: Pishdadian, Abbas, et al.
Publicado: (2016)

In Vitro Evaluation of Allergen Potencies of Commercial House Dust Mite Sublingual Immunotherapy Reagents
por: Park, Kyung Hee, et al.
Publicado: (2015)

Sublingual grass allergen specific immunotherapy: a retrospective study of clinical outcome and discontinuation
por: Janson, Christer, et al.
Publicado: (2018)

Predictors for Short-Term Efficacy of Allergen-Specific Sublingual Immunotherapy in Children with Allergic Rhinitis
por: Liu, Wenlong, et al.
Publicado: (2020)

Safety, Efficacy, and Preventive Role of Subcutaneous and Sublingual Allergen Immunotherapy for the Treatment of Pediatric Asthma
por: Giannetti, Arianna, et al.
Publicado: (2020)

Allergen‐specific immunotherapy with apples: selected cultivars could be a promising tool for birch pollen allergy
por: Nothegger, B., et al.
Publicado: (2020)

A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis
por: Devillier, Philippe, et al.
Publicado: (2014)

Erratum: In Vitro Evaluation of Allergen Potencies of Commercial House Dust Mite Sublingual Immunotherapy Reagents
por: Park, Kyung Hee, et al.
Publicado: (2017)

Sublingual immunotherapy with recombinant Mal d 1 downregulates the allergen‐specific Th2 response
por: Kitzmüller, Claudia, et al.
Publicado: (2019)

Allergen Release Profiles of Fast-Dissolving Freeze-Dried Orodispersible Sublingual Allergy Immunotherapy Tablets
por: Yamamoto, Takashi, et al.
Publicado: (2022)

Immunological Outcomes of Allergen-Specific Immunotherapy in Food Allergy
por: Schoos, Ann-Marie Malby, et al.
Publicado: (2020)

Innovative Systems to Deliver Allergen Powder for Epicutaneous Immunotherapy
por: Wang, Yensheng, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_encclsh1gu9ttgrt99si7qrt9r